Prelude Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 7.00M, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Prelude Therapeutics had annual revenue of 7.00M with Infinity% growth.